1 | iv | 9,837 |
2 | ia | 1,022 |
3 | ib | 530 |
4 | s.c. | 521 |
5 | ii-2 | 54 |
6 | 004 | 52 |
7 | 2x | 48 |
8 | c/d | 48 |
9 | i-v | 40 |
10 | ivpca | 40 |
11 | pt1 | 38 |
12 | hpβcd | 37 |
13 | iic | 36 |
14 | pt2 | 36 |
15 | t3-t4 | 35 |
16 | ib1 | 33 |
17 | mct/lct | 31 |
18 | t3-4 | 25 |
19 | b/c | 24 |
20 | iii-r | 22 |
21 | 0.1mg/kg | 21 |
22 | ii-1 | 19 |
23 | p/d | 18 |
24 | type-iii | 18 |
25 | t1/t2 | 17 |
26 | t2-4 | 16 |
27 | i/v | 15 |
28 | v2.0 | 15 |
29 | 1g/kg | 14 |
30 | 1t | 14 |
31 | i-2 | 14 |
32 | 120mg | 13 |
33 | ii-b | 13 |
34 | 0.5g | 12 |
35 | 1.5mg/kg | 12 |
36 | 24mg/day | 12 |
37 | 2dm | 12 |
38 | custodiol | 12 |
39 | iie | 12 |
40 | vii-viii | 11 |
41 | non-protein-bound | 10 |
42 | pn2 | 10 |
43 | 1000mg/kg | 9 |
44 | 50μm | 9 |
45 | h7n3 | 9 |
46 | mfma | 9 |
47 | mpo-anca | 9 |
48 | 0+ | 8 |
49 | 1/100,000 | 8 |
50 | br.10 | 8 |
51 | c26 | 8 |
52 | goj | 8 |
53 | iib-iii | 8 |
54 | pgex-sj14-3-3 | 8 |
55 | pt3a | 8 |
56 | sdz | 8 |
57 | skp | 8 |
58 | t3/4 | 8 |
59 | t3n1 | 8 |
60 | tf2 | 8 |
61 | vm26 | 8 |
62 | 5×/week | 7 |
63 | b-2 | 7 |
64 | bakumi-jio-gan | 7 |
65 | curosurf® | 7 |
66 | ia/b | 7 |
67 | kl3-4 | 7 |
68 | mclaughlin | 7 |
69 | rhanp | 7 |
70 | s+ | 7 |
71 | 0.125-mg/kg | 6 |
72 | 1.2mg/kg | 6 |
73 | 1/200,000 | 6 |
74 | 1:1,000 | 6 |
75 | 4-ait | 6 |
76 | c4-c6 | 6 |
77 | dhpccb | 6 |
78 | lente | 6 |
79 | non-cyp3a4-met | 6 |
80 | pglcnac | 6 |
81 | preminent® | 6 |
82 | rhil-6 | 6 |
83 | v4.0 | 6 |
84 | 1200mg/day | 5 |
85 | 1:400,000 | 5 |
86 | 296.3 | 5 |
87 | 8s | 5 |
88 | atx-7-q52ha | 5 |
89 | dto | 5 |
90 | f-to-f | 5 |
91 | i/l | 5 |
92 | iii/v | 5 |
93 | listerine® | 5 |
94 | mg-50 | 5 |
95 | preoperative/postoperative | 5 |
96 | pt1-2 | 5 |
97 | s-1+alpha | 5 |
98 | u-100r | 5 |
99 | wbc-containing | 5 |
100 | 10μg | 4 |
101 | 1800mg | 4 |
102 | 2000mg/kg/day | 4 |
103 | 4944 | 4 |
104 | a1.2 | 4 |
105 | arylsulfonyl | 4 |
106 | camts | 4 |
107 | cbt-g | 4 |
108 | e3/e4 | 4 |
109 | hmc3r | 4 |
110 | hsgsk-3 | 4 |
111 | ia-iib | 4 |
112 | ib-iv | 4 |
113 | imy | 4 |
114 | iuv | 4 |
115 | kgt | 4 |
116 | medial/central | 4 |
117 | omocianine | 4 |
118 | open-ove | 4 |
119 | pharmajet | 4 |
120 | pt3r1 | 4 |
121 | qqd | 4 |
122 | sira | 4 |
123 | t2-t4a | 4 |
124 | valgancyclovir | 4 |
125 | 2-ndhsa | 3 |
126 | 20iu | 3 |
127 | 2mg/ml | 3 |
128 | 3.0mg/kg | 3 |
129 | 35/53 | 3 |
130 | 37.5mg | 3 |
131 | 44/52 | 3 |
132 | 5.2.2 | 3 |
133 | 50k | 3 |
134 | 7529 | 3 |
135 | control-ab | 3 |
136 | daily/weekly | 3 |
137 | dcfda | 3 |
138 | dothideomycetes | 3 |
139 | egfrm | 3 |
140 | fd3m | 3 |
141 | fec90 | 3 |
142 | flavedo | 3 |
143 | gen-ttz | 3 |
144 | ginsan | 3 |
145 | hk-gbs | 3 |
146 | hpaepics | 3 |
147 | hsft | 3 |
148 | hsta | 3 |
149 | hubble-bubble | 3 |
150 | il-2/ig | 3 |
151 | infection-unrelated | 3 |
152 | infusion/bolus | 3 |
153 | iv-g | 3 |
154 | iv-s | 3 |
155 | ketamine/placebo | 3 |
156 | letter-in-xs | 3 |
157 | mcc/hib-tt | 3 |
158 | melan | 3 |
159 | moderate-dex | 3 |
160 | nb2c | 3 |
161 | near-sightedness | 3 |
162 | nngngb | 3 |
163 | non-chilled | 3 |
164 | nonconductive | 3 |
165 | parotid-sparing | 3 |
166 | phbv-s | 3 |
167 | pt1n0m0 | 3 |
168 | radioembolisation | 3 |
169 | repsfc | 3 |
170 | restore4stroke | 3 |
171 | sbvc-hc | 3 |
172 | sg/tiz | 3 |
173 | slng | 3 |
174 | stta | 3 |
175 | t2b-4 | 3 |
176 | tac-nx | 3 |
177 | vasc- | 3 |
178 | wwo | 3 |
179 | zyplast | 3 |
180 | 0.15-mg/kg | 2 |
181 | 1.769 | 2 |
182 | 12.8nmol/kg | 2 |
183 | 19750 | 2 |
184 | 20g/d | 2 |
185 | 21.3±0.36c | 2 |
186 | 4-ethylphenyl | 2 |
187 | 400μm | 2 |
188 | 42/55 | 2 |
189 | 4511 | 2 |
190 | 52/77 | 2 |
191 | 5·04 | 2 |
192 | 60-120mg | 2 |
193 | 9.6nmol/kg | 2 |
194 | agroup | 2 |
195 | algonot-plus | 2 |
196 | antivolume | 2 |
197 | bmf-7 | 2 |
198 | bovikalc | 2 |
199 | chestiness | 2 |
200 | clf/lp | 2 |
201 | ct2a | 2 |
202 | dlno | 2 |
203 | emg1 | 2 |
204 | eoc/ppc | 2 |
205 | ep-dwi | 2 |
206 | eskalith | 2 |
207 | extralight | 2 |
208 | fdr-gem | 2 |
209 | feun | 2 |
210 | flixotide | 2 |
211 | forteo | 2 |
212 | germanyne | 2 |
213 | h-bt | 2 |
214 | hcort | 2 |
215 | heterotropic | 2 |
216 | hif-1α-negative | 2 |
217 | hkeb | 2 |
218 | hm-1-ido | 2 |
219 | hour-1 | 2 |
220 | house-bound | 2 |
221 | hpn-100 | 2 |
222 | ia/iia | 2 |
223 | icg3 | 2 |
224 | ifbg | 2 |
225 | iii-n1 | 2 |
226 | iiib-iiic | 2 |
227 | ilio-inguinal | 2 |
228 | imidocarb/glycopyrrolate | 2 |
229 | k101e | 2 |
230 | k70e | 2 |
231 | kcnj6 | 2 |
232 | l861q | 2 |
233 | lg/lg | 2 |
234 | litramine | 2 |
235 | mannans | 2 |
236 | modified-dose | 2 |
237 | mps-3 | 2 |
238 | n=1227 | 2 |
239 | nac-β-end | 2 |
240 | nd50 | 2 |
241 | needle/trocar | 2 |
242 | nk-induced | 2 |
243 | non-demyelinating | 2 |
244 | nras-mutant | 2 |
245 | number/total | 2 |
246 | o2* | 2 |
247 | palpation+ruler | 2 |
248 | pasc | 2 |
249 | pbudce4.1 | 2 |
250 | post-detorsion | 2 |
251 | pro-cpy | 2 |
252 | pt1-3n0m0 | 2 |
253 | pt3a/b | 2 |
254 | rcs5 | 2 |
255 | rmug-s | 2 |
256 | roughcoat | 2 |
257 | rsd1235 | 2 |
258 | s/o | 2 |
259 | saq/ubq-h | 2 |
260 | screen* | 2 |
261 | skyepharma | 2 |
262 | steroiso | 2 |
263 | stratis | 2 |
264 | strawberry-flavoured | 2 |
265 | t1-t2n0 | 2 |
266 | t3n2 | 2 |
267 | t4b | 2 |
268 | tati | 2 |
269 | ti-control | 2 |
270 | trimacinolone | 2 |
271 | umpi | 2 |
272 | vc/t | 2 |
273 | wea | 2 |
274 | whpr | 2 |
275 | β-lph | 2 |
276 | 'mini | 1 |
277 | 0-iiib | 1 |
278 | 1.intramuscular | 1 |
279 | 10-mg/kg-1 | 1 |
280 | 100,000-u | 1 |
281 | 142-145 | 1 |
282 | 1500-1000 | 1 |
283 | 161-137 | 1 |
284 | 1b/1c | 1 |
285 | 2-iv | 1 |
286 | 20-200microg | 1 |
287 | 2695-2589 | 1 |
288 | 2iia | 1 |
289 | 3-im | 1 |
290 | 3gx1 | 1 |
291 | 3h-glucose | 1 |
292 | 4500-1500 | 1 |
293 | 460-377 | 1 |
294 | 4b/5 | 1 |
295 | 5-6.5 | 1 |
296 | 50x8-s | 1 |
297 | 60/75 | 1 |
298 | a*-c. | 1 |
299 | a=intradermal | 1 |
300 | alhydrogel®-formulated | 1 |
301 | b-early | 1 |
302 | b-oral | 1 |
303 | b=intramuscular | 1 |
304 | c=intramuscular | 1 |
305 | contigen® | 1 |
306 | creteil | 1 |
307 | d=intramuscular | 1 |
308 | epopoetin | 1 |
309 | estii | 1 |
310 | fe/kg/d | 1 |
311 | foamotic | 1 |
312 | fragment-c | 1 |
313 | gadoterade | 1 |
314 | graded-glucose | 1 |
315 | hubefore | 1 |
316 | i-ii-iiia | 1 |
317 | i-laparoscopic | 1 |
318 | ia-b | 1 |
319 | ia-iv | 1 |
320 | ib/ic-recommended | 1 |
321 | ii-open | 1 |
322 | iii-case-control | 1 |
323 | iii/iva/ivb | 1 |
324 | ip-1 | 1 |
325 | ip-2+3 | 1 |
326 | iv-case | 1 |
327 | iv/locally | 1 |
328 | marcain® | 1 |
329 | nsie- | 1 |
330 | ocular/cutaneous | 1 |
331 | pbem10 | 1 |
332 | post-mifepristone | 1 |
333 | power-wp | 1 |
334 | propofol/+ | 1 |
335 | range=0-10 | 1 |
336 | rutile/anatase | 1 |
337 | side-windows | 1 |
338 | stnt-based | 1 |
339 | sumart/nap-85mg | 1 |
340 | svi-x | 1 |
341 | t-35 | 1 |
342 | t1m | 1 |
343 | th-l | 1 |
344 | ut3/4 | 1 |
1 | 'mini | 1 |
2 | 0+ | 8 |
3 | 0-iiib | 1 |
4 | 0.125-mg/kg | 6 |
5 | 0.15-mg/kg | 2 |
6 | 0.1mg/kg | 21 |
7 | 0.5g | 12 |
8 | 004 | 52 |
9 | 1.2mg/kg | 6 |
10 | 1.5mg/kg | 12 |
11 | 1.769 | 2 |
12 | 1.intramuscular | 1 |
13 | 1/100,000 | 8 |
14 | 1/200,000 | 6 |
15 | 10-mg/kg-1 | 1 |
16 | 100,000-u | 1 |
17 | 1000mg/kg | 9 |
18 | 10μg | 4 |
19 | 12.8nmol/kg | 2 |
20 | 1200mg/day | 5 |
21 | 120mg | 13 |
22 | 142-145 | 1 |
23 | 1500-1000 | 1 |
24 | 161-137 | 1 |
25 | 1800mg | 4 |
26 | 19750 | 2 |
27 | 1:1,000 | 6 |
28 | 1:400,000 | 5 |
29 | 1b/1c | 1 |
30 | 1g/kg | 14 |
31 | 1t | 14 |
32 | 2-iv | 1 |
33 | 2-ndhsa | 3 |
34 | 20-200microg | 1 |
35 | 2000mg/kg/day | 4 |
36 | 20g/d | 2 |
37 | 20iu | 3 |
38 | 21.3±0.36c | 2 |
39 | 24mg/day | 12 |
40 | 2695-2589 | 1 |
41 | 296.3 | 5 |
42 | 2dm | 12 |
43 | 2iia | 1 |
44 | 2mg/ml | 3 |
45 | 2x | 48 |
46 | 3-im | 1 |
47 | 3.0mg/kg | 3 |
48 | 35/53 | 3 |
49 | 37.5mg | 3 |
50 | 3gx1 | 1 |
51 | 3h-glucose | 1 |
52 | 4-ait | 6 |
53 | 4-ethylphenyl | 2 |
54 | 400μm | 2 |
55 | 42/55 | 2 |
56 | 44/52 | 3 |
57 | 4500-1500 | 1 |
58 | 4511 | 2 |
59 | 460-377 | 1 |
60 | 4944 | 4 |
61 | 4b/5 | 1 |
62 | 5-6.5 | 1 |
63 | 5.2.2 | 3 |
64 | 50k | 3 |
65 | 50x8-s | 1 |
66 | 50μm | 9 |
67 | 52/77 | 2 |
68 | 5·04 | 2 |
69 | 5×/week | 7 |
70 | 60-120mg | 2 |
71 | 60/75 | 1 |
72 | 7529 | 3 |
73 | 8s | 5 |
74 | 9.6nmol/kg | 2 |
75 | a*-c. | 1 |
76 | a1.2 | 4 |
77 | a=intradermal | 1 |
78 | agroup | 2 |
79 | algonot-plus | 2 |
80 | alhydrogel®-formulated | 1 |
81 | antivolume | 2 |
82 | arylsulfonyl | 4 |
83 | atx-7-q52ha | 5 |
84 | b-2 | 7 |
85 | b-early | 1 |
86 | b-oral | 1 |
87 | b/c | 24 |
88 | b=intramuscular | 1 |
89 | bakumi-jio-gan | 7 |
90 | bmf-7 | 2 |
91 | bovikalc | 2 |
92 | br.10 | 8 |
93 | c/d | 48 |
94 | c26 | 8 |
95 | c4-c6 | 6 |
96 | c=intramuscular | 1 |
97 | camts | 4 |
98 | cbt-g | 4 |
99 | chestiness | 2 |
100 | clf/lp | 2 |
101 | contigen® | 1 |
102 | control-ab | 3 |
103 | creteil | 1 |
104 | ct2a | 2 |
105 | curosurf® | 7 |
106 | custodiol | 12 |
107 | d=intramuscular | 1 |
108 | daily/weekly | 3 |
109 | dcfda | 3 |
110 | dhpccb | 6 |
111 | dlno | 2 |
112 | dothideomycetes | 3 |
113 | dto | 5 |
114 | e3/e4 | 4 |
115 | egfrm | 3 |
116 | emg1 | 2 |
117 | eoc/ppc | 2 |
118 | ep-dwi | 2 |
119 | epopoetin | 1 |
120 | eskalith | 2 |
121 | estii | 1 |
122 | extralight | 2 |
123 | f-to-f | 5 |
124 | fd3m | 3 |
125 | fdr-gem | 2 |
126 | fe/kg/d | 1 |
127 | fec90 | 3 |
128 | feun | 2 |
129 | flavedo | 3 |
130 | flixotide | 2 |
131 | foamotic | 1 |
132 | forteo | 2 |
133 | fragment-c | 1 |
134 | gadoterade | 1 |
135 | gen-ttz | 3 |
136 | germanyne | 2 |
137 | ginsan | 3 |
138 | goj | 8 |
139 | graded-glucose | 1 |
140 | h-bt | 2 |
141 | h7n3 | 9 |
142 | hcort | 2 |
143 | heterotropic | 2 |
144 | hif-1α-negative | 2 |
145 | hk-gbs | 3 |
146 | hkeb | 2 |
147 | hm-1-ido | 2 |
148 | hmc3r | 4 |
149 | hour-1 | 2 |
150 | house-bound | 2 |
151 | hpaepics | 3 |
152 | hpn-100 | 2 |
153 | hpβcd | 37 |
154 | hsft | 3 |
155 | hsgsk-3 | 4 |
156 | hsta | 3 |
157 | hubble-bubble | 3 |
158 | hubefore | 1 |
159 | i-2 | 14 |
160 | i-ii-iiia | 1 |
161 | i-laparoscopic | 1 |
162 | i-v | 40 |
163 | i/l | 5 |
164 | i/v | 15 |
165 | ia | 1,022 |
166 | ia-b | 1 |
167 | ia-iib | 4 |
168 | ia-iv | 1 |
169 | ia/b | 7 |
170 | ia/iia | 2 |
171 | ib | 530 |
172 | ib-iv | 4 |
173 | ib/ic-recommended | 1 |
174 | ib1 | 33 |
175 | icg3 | 2 |
176 | ifbg | 2 |
177 | ii-1 | 19 |
178 | ii-2 | 54 |
179 | ii-b | 13 |
180 | ii-open | 1 |
181 | iib-iii | 8 |
182 | iic | 36 |
183 | iie | 12 |
184 | iii-case-control | 1 |
185 | iii-n1 | 2 |
186 | iii-r | 22 |
187 | iii/iva/ivb | 1 |
188 | iii/v | 5 |
189 | iiib-iiic | 2 |
190 | il-2/ig | 3 |
191 | ilio-inguinal | 2 |
192 | imidocarb/glycopyrrolate | 2 |
193 | imy | 4 |
194 | infection-unrelated | 3 |
195 | infusion/bolus | 3 |
196 | ip-1 | 1 |
197 | ip-2+3 | 1 |
198 | iuv | 4 |
199 | iv | 9,837 |
200 | iv-case | 1 |
201 | iv-g | 3 |
202 | iv-s | 3 |
203 | iv/locally | 1 |
204 | ivpca | 40 |
205 | k101e | 2 |
206 | k70e | 2 |
207 | kcnj6 | 2 |
208 | ketamine/placebo | 3 |
209 | kgt | 4 |
210 | kl3-4 | 7 |
211 | l861q | 2 |
212 | lente | 6 |
213 | letter-in-xs | 3 |
214 | lg/lg | 2 |
215 | listerine® | 5 |
216 | litramine | 2 |
217 | mannans | 2 |
218 | marcain® | 1 |
219 | mcc/hib-tt | 3 |
220 | mclaughlin | 7 |
221 | mct/lct | 31 |
222 | medial/central | 4 |
223 | melan | 3 |
224 | mfma | 9 |
225 | mg-50 | 5 |
226 | moderate-dex | 3 |
227 | modified-dose | 2 |
228 | mpo-anca | 9 |
229 | mps-3 | 2 |
230 | n=1227 | 2 |
231 | nac-β-end | 2 |
232 | nb2c | 3 |
233 | nd50 | 2 |
234 | near-sightedness | 3 |
235 | needle/trocar | 2 |
236 | nk-induced | 2 |
237 | nngngb | 3 |
238 | non-chilled | 3 |
239 | non-cyp3a4-met | 6 |
240 | non-demyelinating | 2 |
241 | non-protein-bound | 10 |
242 | nonconductive | 3 |
243 | nras-mutant | 2 |
244 | nsie- | 1 |
245 | number/total | 2 |
246 | o2* | 2 |
247 | ocular/cutaneous | 1 |
248 | omocianine | 4 |
249 | open-ove | 4 |
250 | p/d | 18 |
251 | palpation+ruler | 2 |
252 | parotid-sparing | 3 |
253 | pasc | 2 |
254 | pbem10 | 1 |
255 | pbudce4.1 | 2 |
256 | pgex-sj14-3-3 | 8 |
257 | pglcnac | 6 |
258 | pharmajet | 4 |
259 | phbv-s | 3 |
260 | pn2 | 10 |
261 | post-detorsion | 2 |
262 | post-mifepristone | 1 |
263 | power-wp | 1 |
264 | preminent® | 6 |
265 | preoperative/postoperative | 5 |
266 | pro-cpy | 2 |
267 | propofol/+ | 1 |
268 | pt1 | 38 |
269 | pt1-2 | 5 |
270 | pt1-3n0m0 | 2 |
271 | pt1n0m0 | 3 |
272 | pt2 | 36 |
273 | pt3a | 8 |
274 | pt3a/b | 2 |
275 | pt3r1 | 4 |
276 | qqd | 4 |
277 | radioembolisation | 3 |
278 | range=0-10 | 1 |
279 | rcs5 | 2 |
280 | repsfc | 3 |
281 | restore4stroke | 3 |
282 | rhanp | 7 |
283 | rhil-6 | 6 |
284 | rmug-s | 2 |
285 | roughcoat | 2 |
286 | rsd1235 | 2 |
287 | rutile/anatase | 1 |
288 | s+ | 7 |
289 | s-1+alpha | 5 |
290 | s.c. | 521 |
291 | s/o | 2 |
292 | saq/ubq-h | 2 |
293 | sbvc-hc | 3 |
294 | screen* | 2 |
295 | sdz | 8 |
296 | sg/tiz | 3 |
297 | side-windows | 1 |
298 | sira | 4 |
299 | skp | 8 |
300 | skyepharma | 2 |
301 | slng | 3 |
302 | steroiso | 2 |
303 | stnt-based | 1 |
304 | stratis | 2 |
305 | strawberry-flavoured | 2 |
306 | stta | 3 |
307 | sumart/nap-85mg | 1 |
308 | svi-x | 1 |
309 | t-35 | 1 |
310 | t1-t2n0 | 2 |
311 | t1/t2 | 17 |
312 | t1m | 1 |
313 | t2-4 | 16 |
314 | t2-t4a | 4 |
315 | t2b-4 | 3 |
316 | t3-4 | 25 |
317 | t3-t4 | 35 |
318 | t3/4 | 8 |
319 | t3n1 | 8 |
320 | t3n2 | 2 |
321 | t4b | 2 |
322 | tac-nx | 3 |
323 | tati | 2 |
324 | tf2 | 8 |
325 | th-l | 1 |
326 | ti-control | 2 |
327 | trimacinolone | 2 |
328 | type-iii | 18 |
329 | u-100r | 5 |
330 | umpi | 2 |
331 | ut3/4 | 1 |
332 | v2.0 | 15 |
333 | v4.0 | 6 |
334 | valgancyclovir | 4 |
335 | vasc- | 3 |
336 | vc/t | 2 |
337 | vii-viii | 11 |
338 | vm26 | 8 |
339 | wbc-containing | 5 |
340 | wea | 2 |
341 | whpr | 2 |
342 | wwo | 3 |
343 | zyplast | 3 |
344 | β-lph | 2 |
1 | o2* | 2 |
2 | screen* | 2 |
3 | propofol/+ | 1 |
4 | 0+ | 8 |
5 | s+ | 7 |
6 | vasc- | 3 |
7 | nsie- | 1 |
8 | a*-c. | 1 |
9 | s.c. | 521 |
10 | v2.0 | 15 |
11 | v4.0 | 6 |
12 | 1/100,000 | 8 |
13 | 1/200,000 | 6 |
14 | 1:400,000 | 5 |
15 | 1:1,000 | 6 |
16 | 1500-1000 | 1 |
17 | hpn-100 | 2 |
18 | 4500-1500 | 1 |
19 | range=0-10 | 1 |
20 | br.10 | 8 |
21 | pbem10 | 1 |
22 | mg-50 | 5 |
23 | 19750 | 2 |
24 | nd50 | 2 |
25 | fec90 | 3 |
26 | pt1n0m0 | 3 |
27 | pt1-3n0m0 | 2 |
28 | t1-t2n0 | 2 |
29 | 10-mg/kg-1 | 1 |
30 | ii-1 | 19 |
31 | ip-1 | 1 |
32 | hour-1 | 2 |
33 | pbudce4.1 | 2 |
34 | 4511 | 2 |
35 | ib1 | 33 |
36 | emg1 | 2 |
37 | iii-n1 | 2 |
38 | t3n1 | 8 |
39 | pt3r1 | 4 |
40 | pt1 | 38 |
41 | 3gx1 | 1 |
42 | pt1-2 | 5 |
43 | b-2 | 7 |
44 | i-2 | 14 |
45 | ii-2 | 54 |
46 | a1.2 | 4 |
47 | 5.2.2 | 3 |
48 | 44/52 | 3 |
49 | tf2 | 8 |
50 | t3n2 | 2 |
51 | pn2 | 10 |
52 | t1/t2 | 17 |
53 | pt2 | 36 |
54 | ip-2+3 | 1 |
55 | pgex-sj14-3-3 | 8 |
56 | hsgsk-3 | 4 |
57 | mps-3 | 2 |
58 | 296.3 | 5 |
59 | 35/53 | 3 |
60 | icg3 | 2 |
61 | h7n3 | 9 |
62 | t2-4 | 16 |
63 | kl3-4 | 7 |
64 | t3-4 | 25 |
65 | t2b-4 | 3 |
66 | t3/4 | 8 |
67 | ut3/4 | 1 |
68 | 004 | 52 |
69 | 5·04 | 2 |
70 | 4944 | 4 |
71 | e3/e4 | 4 |
72 | t3-t4 | 35 |
73 | 5-6.5 | 1 |
74 | 4b/5 | 1 |
75 | t-35 | 1 |
76 | rsd1235 | 2 |
77 | 142-145 | 1 |
78 | 42/55 | 2 |
79 | 60/75 | 1 |
80 | rcs5 | 2 |
81 | rhil-6 | 6 |
82 | c26 | 8 |
83 | vm26 | 8 |
84 | c4-c6 | 6 |
85 | kcnj6 | 2 |
86 | bmf-7 | 2 |
87 | n=1227 | 2 |
88 | 161-137 | 1 |
89 | 52/77 | 2 |
90 | 460-377 | 1 |
91 | 7529 | 3 |
92 | 1.769 | 2 |
93 | 2695-2589 | 1 |
94 | ct2a | 2 |
95 | pt3a | 8 |
96 | t2-t4a | 4 |
97 | mpo-anca | 9 |
98 | ivpca | 40 |
99 | dcfda | 3 |
100 | wea | 2 |
101 | atx-7-q52ha | 5 |
102 | s-1+alpha | 5 |
103 | ia | 1,022 |
104 | ia/iia | 2 |
105 | 2iia | 1 |
106 | i-ii-iiia | 1 |
107 | mfma | 9 |
108 | skyepharma | 2 |
109 | sira | 4 |
110 | 2-ndhsa | 3 |
111 | hsta | 3 |
112 | stta | 3 |
113 | ia-b | 1 |
114 | ii-b | 13 |
115 | pt3a/b | 2 |
116 | ia/b | 7 |
117 | t4b | 2 |
118 | control-ab | 3 |
119 | dhpccb | 6 |
120 | hkeb | 2 |
121 | nngngb | 3 |
122 | ib | 530 |
123 | ia-iib | 4 |
124 | 0-iiib | 1 |
125 | iii/iva/ivb | 1 |
126 | fragment-c | 1 |
127 | b/c | 24 |
128 | 1b/1c | 1 |
129 | nb2c | 3 |
130 | 21.3±0.36c | 2 |
131 | pglcnac | 6 |
132 | repsfc | 3 |
133 | sbvc-hc | 3 |
134 | iic | 36 |
135 | iiib-iiic | 2 |
136 | i-laparoscopic | 1 |
137 | heterotropic | 2 |
138 | foamotic | 1 |
139 | bovikalc | 2 |
140 | eoc/ppc | 2 |
141 | pasc | 2 |
142 | c/d | 48 |
143 | 20g/d | 2 |
144 | fe/kg/d | 1 |
145 | p/d | 18 |
146 | hpβcd | 37 |
147 | nk-induced | 2 |
148 | ib/ic-recommended | 1 |
149 | non-chilled | 3 |
150 | strawberry-flavoured | 2 |
151 | stnt-based | 1 |
152 | infection-unrelated | 3 |
153 | alhydrogel®-formulated | 1 |
154 | nac-β-end | 2 |
155 | house-bound | 2 |
156 | non-protein-bound | 10 |
157 | qqd | 4 |
158 | k70e | 2 |
159 | k101e | 2 |
160 | gadoterade | 1 |
161 | flixotide | 2 |
162 | iie | 12 |
163 | restore4stroke | 3 |
164 | hubble-bubble | 3 |
165 | antivolume | 2 |
166 | litramine | 2 |
167 | omocianine | 4 |
168 | trimacinolone | 2 |
169 | post-mifepristone | 1 |
170 | germanyne | 2 |
171 | hubefore | 1 |
172 | iv-case | 1 |
173 | rutile/anatase | 1 |
174 | graded-glucose | 1 |
175 | 3h-glucose | 1 |
176 | modified-dose | 2 |
177 | imidocarb/glycopyrrolate | 2 |
178 | lente | 6 |
179 | hif-1α-negative | 2 |
180 | preoperative/postoperative | 5 |
181 | nonconductive | 3 |
182 | open-ove | 4 |
183 | f-to-f | 5 |
184 | cbt-g | 4 |
185 | iv-g | 3 |
186 | 0.5g | 12 |
187 | ifbg | 2 |
188 | il-2/ig | 3 |
189 | 1g/kg | 14 |
190 | 0.15-mg/kg | 2 |
191 | 0.125-mg/kg | 6 |
192 | 3.0mg/kg | 3 |
193 | 1000mg/kg | 9 |
194 | 0.1mg/kg | 21 |
195 | 1.2mg/kg | 6 |
196 | 1.5mg/kg | 12 |
197 | 9.6nmol/kg | 2 |
198 | 12.8nmol/kg | 2 |
199 | lg/lg | 2 |
200 | 1800mg | 4 |
201 | 120mg | 13 |
202 | 60-120mg | 2 |
203 | 37.5mg | 3 |
204 | sumart/nap-85mg | 1 |
205 | wbc-containing | 5 |
206 | parotid-sparing | 3 |
207 | non-demyelinating | 2 |
208 | slng | 3 |
209 | 20-200microg | 1 |
210 | 10μg | 4 |
211 | saq/ubq-h | 2 |
212 | β-lph | 2 |
213 | eskalith | 2 |
214 | iib-iii | 8 |
215 | type-iii | 18 |
216 | vii-viii | 11 |
217 | estii | 1 |
218 | 'mini | 1 |
219 | umpi | 2 |
220 | tati | 2 |
221 | ep-dwi | 2 |
222 | goj | 8 |
223 | 50k | 3 |
224 | 5×/week | 7 |
225 | th-l | 1 |
226 | i/l | 5 |
227 | a=intradermal | 1 |
228 | ilio-inguinal | 2 |
229 | b-oral | 1 |
230 | medial/central | 4 |
231 | number/total | 2 |
232 | creteil | 1 |
233 | 2mg/ml | 3 |
234 | custodiol | 12 |
235 | iii-case-control | 1 |
236 | ti-control | 2 |
237 | 4-ethylphenyl | 2 |
238 | arylsulfonyl | 4 |
239 | t1m | 1 |
240 | fd3m | 3 |
241 | 2dm | 12 |
242 | fdr-gem | 2 |
243 | 3-im | 1 |
244 | egfrm | 3 |
245 | 400μm | 2 |
246 | 50μm | 9 |
247 | bakumi-jio-gan | 7 |
248 | melan | 3 |
249 | ginsan | 3 |
250 | ii-open | 1 |
251 | mclaughlin | 7 |
252 | epopoetin | 1 |
253 | post-detorsion | 2 |
254 | radioembolisation | 3 |
255 | feun | 2 |
256 | s/o | 2 |
257 | ketamine/placebo | 3 |
258 | flavedo | 3 |
259 | hm-1-ido | 2 |
260 | forteo | 2 |
261 | dlno | 2 |
262 | steroiso | 2 |
263 | dto | 5 |
264 | wwo | 3 |
265 | skp | 8 |
266 | clf/lp | 2 |
267 | rhanp | 7 |
268 | agroup | 2 |
269 | power-wp | 1 |
270 | l861q | 2 |
271 | iii-r | 22 |
272 | u-100r | 5 |
273 | hmc3r | 4 |
274 | needle/trocar | 2 |
275 | 1.intramuscular | 1 |
276 | b=intramuscular | 1 |
277 | c=intramuscular | 1 |
278 | d=intramuscular | 1 |
279 | palpation+ruler | 2 |
280 | valgancyclovir | 4 |
281 | whpr | 2 |
282 | 50x8-s | 1 |
283 | rmug-s | 2 |
284 | phbv-s | 3 |
285 | iv-s | 3 |
286 | 8s | 5 |
287 | hk-gbs | 3 |
288 | hpaepics | 3 |
289 | dothideomycetes | 3 |
290 | stratis | 2 |
291 | mannans | 2 |
292 | near-sightedness | 3 |
293 | chestiness | 2 |
294 | camts | 4 |
295 | infusion/bolus | 3 |
296 | algonot-plus | 2 |
297 | ocular/cutaneous | 1 |
298 | side-windows | 1 |
299 | letter-in-xs | 3 |
300 | vc/t | 2 |
301 | 1t | 14 |
302 | roughcoat | 2 |
303 | h-bt | 2 |
304 | mct/lct | 31 |
305 | pharmajet | 4 |
306 | non-cyp3a4-met | 6 |
307 | hsft | 3 |
308 | kgt | 4 |
309 | extralight | 2 |
310 | 4-ait | 6 |
311 | nras-mutant | 2 |
312 | hcort | 2 |
313 | zyplast | 3 |
314 | mcc/hib-tt | 3 |
315 | 100,000-u | 1 |
316 | 20iu | 3 |
317 | i-v | 40 |
318 | i/v | 15 |
319 | iii/v | 5 |
320 | iv | 9,837 |
321 | 2-iv | 1 |
322 | ia-iv | 1 |
323 | ib-iv | 4 |
324 | iuv | 4 |
325 | svi-x | 1 |
326 | 2x | 48 |
327 | moderate-dex | 3 |
328 | tac-nx | 3 |
329 | 2000mg/kg/day | 4 |
330 | 1200mg/day | 5 |
331 | 24mg/day | 12 |
332 | daily/weekly | 3 |
333 | iv/locally | 1 |
334 | b-early | 1 |
335 | imy | 4 |
336 | pro-cpy | 2 |
337 | sdz | 8 |
338 | sg/tiz | 3 |
339 | gen-ttz | 3 |
340 | listerine® | 5 |
341 | curosurf® | 7 |
342 | contigen® | 1 |
343 | marcain® | 1 |
344 | preminent® | 6 |